Efficacy and safety of galcanezumab for prevention of migraine headache in Japanese patients with episodic migraine: A phase 2 randomized controlled clinical trial

• Published in: Cephalalgia reports Vol. 3
• Main Authors: Sakai, Fumihiko, Ozeki, Akichika, Skljarevski, Vladimir
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 2020; Sage Publications Ltd; SAGE Publishing
• Subjects: Clinical trials; Erythema; Headache; Headaches; Migraine; Monoclonal antibodies; Patients; Pruritus; LY2951742; episodic migraine; migraine; galcanezumab; Japan; preventive therapy; calcitonin gene-related peptide; CGRP

Objective: This study was designed to assess the efficacy and safety of galcanezumab in comparison with placebo for the prevention of migraine in Japanese patients with episodic migraine. Methods: In this double-blind, placebo-controlled study, which was conducted over 6 months, randomized adult pat...